Evercore ISI says three years of biotech underperformance may be ending. Gives its 5 favorite stocks
Evercore initiated coverage on the biotech sector and named its seven favorite stocks it calls "The Magnificent Seven." Source link
Read MoreEvercore initiated coverage on the biotech sector and named its seven favorite stocks it calls "The Magnificent Seven." Source link
Read MoreAlphabet and Meta Platforms are among the most recent high-profile names to initiate a dividend to give back to shareholders.
Read MoreAnti-obesity drugmakers Novo Nordisk and Eli Lilly have a huge lead on their competition, but it's coming. Source link
Read MoreCNBC's Jim Cramer told investors to pay attention next week to the JPMorgan Healthcare Conference. Source link
Read MoreOprah Winfrey has changed her mind on weight loss drugs and others have, too. What's ahead for the category in
Read MorePiper Sandler analyst Allison Bratzel said the loss of lean muscle while taking GLP-1 drugs is "a major shortcoming" that
Read MoreRegeneron's Dupixent drug could serve as the next big catalyst for shares of the pharmaceutical company, according to Jefferies.
Read MoreHere are the biggest calls on Wall Street on Source link
Read MoreA recap of Friday's best stock picks on CNBC. Source link
Read More